Alaye siwaju sii ― Yoruba

Urticaria ti o wọpọ julọ ṣafihan pẹlu awọn welti tí ó ga ní awọ. Nígbà míì, ó lè wá pẹ̀lú wiwu àwọn ara abẹ́lẹ̀. Itọju àkọ́kọ́ ni yiyọkuro àwọn okunfa tí ó mọ̀. Oògùn laini àkọ́kọ́ ni antihistamines tuntun, tí a lè pọ̀ sí ìwọn tó gíga bí ó bá wúlò. Àwọn oògùn míì bí antihistamines atijọ, H2 blockers, leukotriene receptor antagonists, antihistamines tó lagbara, àti corticosteroids kukuru lè ṣàfikún gẹ́gẹ́ bí ìtìlẹ́yìn míì. Ní àwọn ọ̀ràn tí urticaria bá ń tẹ̀síwájú láì dáhùn sí àwọn ìlànà wọ̀nyí, àwọn aláìsàn lè tọ́ka sí amọ̀ja fún ìtọ́jú míì bí omalizumab tàbí cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Atunwo yii ṣe apejuwe awọn ilana titun fun itọju urticaria ati pe o funni ni oye titun nipa awọn idi rẹ.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids